KORKMAZ, O. T. Et Al. 2017. VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE. 13. Inetrnetional Symposium on VIP, PACAP and related peptides .

KORKMAZ, O. T., AY, H., AYTAN, N., CARRERAS, I., KOWALL, N., DEDEOĞLU, A., ... TUNÇEL, A. N.(2017). VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE . 13. Inetrnetional Symposium on VIP, PACAP and related peptides

KORKMAZ, ORHAN Et Al. "VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE," 13. Inetrnetional Symposium on VIP, PACAP and related peptides, 2017

KORKMAZ, ORHAN T. Et Al. "VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE." 13. Inetrnetional Symposium on VIP, PACAP and related peptides , 2017

KORKMAZ, O. T. Et Al. (2017) . "VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE." 13. Inetrnetional Symposium on VIP, PACAP and related peptides .

@conferencepaper{conferencepaper, author={ORHAN TANSEL KORKMAZ Et Al. }, title={VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE}, congress name={13. Inetrnetional Symposium on VIP, PACAP and related peptides}, city={}, country={}, year={2017}}